Novo Nordisk A/S has initiated a share repurchase programme, as reported by Taiwan News.

Morgan Stanley has upgraded Novo Nordisk A/S (NVO) from Underweight to Equal Weight, providing an explanation for the change in its investment rating.

Swati Pradhan sees about 12 obesity patients a day at her clinic in southern Mumbai. She expects this number to at least double from this month as Indian drug makers prepare to launch off-patent versions of Novo Nordisk A/S's blockbuster weight.

Novo Nordisk A/S has announced that its drug Sogroya received FDA approval for three new indications.

Novo Nordisk A/S and Vivtex Corporation have announced a new partnership, details of which were not specified in the headline.